Search Results - Eleonora Pagan

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies by Eleonora Pagan, Federico Rea, Matteo Monzio Compagnoni, Anna Cantarutti, Pietro Pugni, Vincenzo Bagnardi, Giovanni Corrao

    Get full text
    Article


  2. 2

    Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs... by Greta Caprara, Eleonora Pagan, Lucilla Titta, Maria Tieri, Giada Magionesi, Silvia Gallosti, Vincenzo Bagnardi, Ketti Mazzocco, Ketti Mazzocco, Manuelita Mazza

    Published in Frontiers in Oncology (2024-09-01)
    Get full text
    Article


  3. 3

    “Heterogeneity of treatment effect on patients’ long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.” by Laura Pala, Isabella Sala, Eleonora Pagan, Tommaso De Pas, Emma Zattarin, Chiara Catania, Emilia Cocorocchio, Giovanna Rossi, Daniele Laszlo, Giovanni Ceresoli, Jacopo Canzian, Elena Valenzi, Vincenzo Bagnardi, Fabio Conforti

    Published in Breast (2024-02-01)
    Get full text
    Article


  4. 4

    Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants by Andrea Lisa, Francesca Riccardi, Mario Alessandri-Bonetti, Luca Mazzocconi, Manuela Bottoni, Benedetta Barbieri, Alessandra Gottardi, Marco Palmesano, Valerio Cervelli, Vincenzo Bagnardi, Eleonora Pagan, Paolo Veronesi, Francesca De Lorenzi, Mario Rietjens

    Published in Breast (2025-10-01)
    Get full text
    Article


  5. 5

    Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical t... by Laura Pala, Tommaso De Pas, Eleonora Pagan, Isabella Sala, Chiara Catania, Emma Zattarin, Paolo Arnone, Massimo M. Grassi, Marco Colleoni, Antonio C. Wolff, Javier Cortes, Martine Piccart, Richard D. Gelber, Giuseppe Viale, Vincenzo Bagnardi, Fabio Conforti

    Published in Breast (2023-06-01)
    Get full text
    Article


  6. 6

    Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis by Isabella Sala, Isabella Sala, Eleonora Pagan, Laura Pala, Chiara Oriecuia, Chiara Oriecuia, Marco Musca, Marco Musca, Claudia Specchia, Tommaso De Pas, Javier Cortes, Javier Cortes, Javier Cortes, Giuseppe Giaccone, Michael Postow, Richard D. Gelber, Vincenzo Bagnardi, Fabio Conforti, Fabio Conforti

    Published in Frontiers in Immunology (2024-01-01)
    Get full text
    Article


  7. 7

    Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysisResearch in context by Laura Pala, Eleonora Pagan, Isabella Sala, Chiara Oriecuia, Matteo Oliari, Tommaso De Pas, Claudia Specchia, Emilia Cocorocchio, Emma Zattarin, Giovanna Rossi, Chiara Catania, Giovanni Luca Ceresoli, Daniele Laszlo, Jacopo Canzian, Elena Valenzi, Giuseppe Viale, Richard D. Gelber, Alberto Mantovani, Vincenzo Bagnardi, Fabio Conforti

    Published in EClinicalMedicine (2024-07-01)
    Get full text
    Article


  8. 8

    Pegylated Liposomal Doxorubicin (Caelyx<sup>®</sup>) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial by Silvia Dellapasqua, Pamela Trillo Aliaga, Elisabetta Munzone, Vincenzo Bagnardi, Eleonora Pagan, Emilia Montagna, Giuseppe Cancello, Raffaella Ghisini, Claudia Sangalli, Mara Negri, Manuelita Mazza, Monica Iorfida, Anna Cardillo, Angela Sciandivasci, Nadia Bianco, Ana Paula De Maio, Monica Milano, Giuseppe Maria Campennì, Loredana Sansonno, Giuseppe Viale, Anna Morra, Maria Cristina Leonardi, Viviana Galimberti, Paolo Veronesi, Marco Colleoni

    Published in Current Oncology (2021-12-01)
    Get full text
    Article


  9. 9

    Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer by Eleonora Pagan, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Markus Borner, Monica Giordano, Lorenzo Gianni, Manuela Rabaglio, Andrea Freschi, Elisabetta Cretella, Elena Seles, Alberto Farolfi, Edda Simoncini, Mariangela Ciccarese, Daniel Rauch, Adolfo Favaretto, Friedemann Honecker, Rossana Berardi, Alessandra Franzetti-Pellanda, Shari Gelber, Ann H. Partridge, Aron Goldhirsch, Vincenzo Bagnardi, Olivia Pagani, Karin Ribi

    Published in Breast (2024-10-01)
    Get full text
    Article


Search Tools: